The aim of this webinar is to update GPs on the management of Osteoporosis in General Practice.

Our speaker:

Professor Ego Seeman, Endocrinologist at the department of Medicine and Endocrinology, Austin Health, and University of Melbourne

By the end of this webinar, participants will be able to:

Use bone remodeling marker, CTX to help decide whether to treat and to monitor treatment.
Review three antiresorptives - Actonel (risedronate), Zoledronic acid (Aclasta) and denosumab (prolia) reduce all three classes of fracture – spine, hip and non-vertebral fractures and do so safely.
Identifying adverse events of osteonecrosis of the jaw and atypical fractures (uncommon events).
Discuss treatment in general, is life-long. Consult before stopping therapy and if stopping, monitor to determine if bone loss recurs.

Delivered in partnership with Partnered Health.

This webinar is pending accreditation by RACGP and ACRRM for 1.5 CPD hours under the Educational Activities category.